179 related articles for article (PubMed ID: 28650703)
21. Loss to Follow-Up within the Prevention of Mother-to-Child Transmission Care Cascade in a Large ART Program in Nigeria.
Rawizza HE; Chang CA; Chaplin B; Ahmed IA; Meloni ST; Oyebode T; Banigbe B; Sagay AS; Adewole IF; Okonkwo P; Kanki PJ;
Curr HIV Res; 2015; 13(3):201-9. PubMed ID: 25986371
[TBL] [Abstract][Full Text] [Related]
22. Implementation and Operational Research: Integration of PMTCT and Antenatal Services Improves Combination Antiretroviral Therapy Uptake for HIV-Positive Pregnant Women in Southern Zambia: A Prototype for Option B+?
Herlihy JM; Hamomba L; Bonawitz R; Goggin CE; Sambambi K; Mwale J; Musonda V; Musokatwane K; Hopkins KL; Semrau K; Hammond EE; Duncan J; Knapp AB; Thea DM
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):e123-9. PubMed ID: 26181813
[TBL] [Abstract][Full Text] [Related]
23. Outcomes in a cohort of women who discontinued maternal triple-antiretroviral regimens initially used to prevent mother-to-child transmission during pregnancy and breastfeeding--Kenya, 2003-2009.
Minniear TD; Girde S; Angira F; Mills LA; Zeh C; Peters PJ; Masaba R; Lando R; Thomas TK; Taylor AW;
PLoS One; 2014; 9(4):e93556. PubMed ID: 24733021
[TBL] [Abstract][Full Text] [Related]
24. Retention, transfer out and loss to follow-up two years after delivery in a cohort of HIV+ pregnant women in Malawi.
Giuliano M; Liotta G; Andreotti M; Mancinelli S; Buonomo E; Scarcella P; Amici R; Jere H; Sagno JB; Di Gregorio M; Marazzi MC; Vella S; Palombi L
Int J STD AIDS; 2016 May; 27(6):462-8. PubMed ID: 25953961
[TBL] [Abstract][Full Text] [Related]
25. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
[TBL] [Abstract][Full Text] [Related]
26. Toward an AIDS-free generation with option B+: reconceptualizing and integrating prevention of mother to child transmission (PMTCT) with pediatric antiretroviral therapy initiatives.
Thyssen A; Lange JH; Thyssen E; Reddi A
J Acquir Immune Defic Syndr; 2013 Feb; 62(2):127-8. PubMed ID: 23018370
[No Abstract] [Full Text] [Related]
27. Viral Suppression and Retention in Care up to 5 Years After Initiation of Lifelong ART During Pregnancy (Option B+) in Rural Uganda.
Koss CA; Natureeba P; Kwarisiima D; Ogena M; Clark TD; Olwoch P; Cohan D; Okiring J; Charlebois ED; Kamya MR; Havlir DV
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):279-284. PubMed ID: 27828878
[TBL] [Abstract][Full Text] [Related]
28. Increasing retention of HIV positive pregnant and breastfeeding mothers on option-b plus by upgrading and providing full time HIV services at a lower health facility in rural Uganda.
Masereka EM; Ngabirano TD; Osingada CP; Wiltshire CS; Castelnuovo B; Kiragga AN
BMC Public Health; 2019 Jul; 19(1):950. PubMed ID: 31307455
[TBL] [Abstract][Full Text] [Related]
29. Does provision of point-of-care CD4 technology and early knowledge of CD4 levels affect early initiation and retention on antiretroviral treatment in HIV-positive pregnant women in the context of Option B+ for PMTCT?
Mangwiro AZ; Makomva K; Bhattacharya A; Bhattacharya G; Gotora T; Owen M; Mushavi A; Mangwanya D; Zinyowera S; Rusakaniko S; Mugurungi O; Zizhou S; Busumani W; Masuka N
J Acquir Immune Defic Syndr; 2014 Nov; 67 Suppl 2():S139-44. PubMed ID: 25310120
[TBL] [Abstract][Full Text] [Related]
30. Implementation of Antiretroviral Therapy for Life in Pregnant/Breastfeeding HIV+ Women (Option B+) Alongside Rollout and Changing Guidelines for ART Initiation in Rural Zimbabwe: The Lablite Project Experience.
Ford D; Muzambi M; Nkhata MJ; Abongomera G; Joseph S; Ndlovu M; Mabugu T; Grundy C; Chan AK; Cataldo F; Kityo C; Seeley J; Katabira E; Gilks CF; Reid A; Hakim J; Gibb DM;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):508-516. PubMed ID: 27984555
[TBL] [Abstract][Full Text] [Related]
31. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi.
Cataldo F; Chiwaula L; Nkhata M; van Lettow M; Kasende F; Rosenberg NE; Tweya H; Sampathkumar V; Hosseinipour M; Schouten E; Kapito-Tembo A; Eliya M; Chimbwandira F; Phiri S;
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):517-522. PubMed ID: 28045712
[TBL] [Abstract][Full Text] [Related]
32. Option B+ Program for the Prevention of Vertical Transmission of HIV: A Case Study in Johannesburg, South Africa.
Bisnauth MA; Coovadia A; Mbuagbaw L; Wilson MG; Birch S
Front Public Health; 2020; 8():533534. PubMed ID: 33194942
[No Abstract] [Full Text] [Related]
33. Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study.
DiCarlo AL; Gachuhi AB; Mthethwa-Hleta S; Shongwe S; Hlophe T; Peters ZJ; Zerbe A; Myer L; Langwenya N; Okello V; Sahabo R; Nuwagaba-Biribonwoha H; Abrams EJ
BMC Health Serv Res; 2019 Apr; 19(1):210. PubMed ID: 30940149
[TBL] [Abstract][Full Text] [Related]
34. Investigation of mother-to-child transmission of HIV in pregnancy and among HIV-exposed infants accessing care at a PMTCT clinic in southwest Nigeria.
Afolabi AY; Bakarey AS; Kolawole OE; Kola OJ
J Immunoassay Immunochem; 2018; 39(4):403-415. PubMed ID: 30001188
[TBL] [Abstract][Full Text] [Related]
35. Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial.
Amone A; Gabagaya G; Wavamunno P; Rukundo G; Namale-Matovu J; Malamba SS; Lubega I; Homsy J; King R; Nakabiito C; Namukwaya Z; Fowler MG; Musoke P
PLoS One; 2024; 19(4):e0297652. PubMed ID: 38640123
[TBL] [Abstract][Full Text] [Related]
36. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.
Hauser BM; Miller WC; Tweya H; Speight C; Mtande T; Phiri S; Ball LM; Hosseinipour MC; Hoffman IF; Rosenberg NE
Int J STD AIDS; 2018 Feb; 29(2):185-194. PubMed ID: 28750577
[TBL] [Abstract][Full Text] [Related]
37. Challenges and successes in the implementation of option B+ to prevent mother-to-child transmission of HIV in southern Swaziland.
Etoori D; Kerschberger B; Staderini N; Ndlangamandla M; Nhlabatsi B; Jobanputra K; Mthethwa-Hleza S; Parker LA; Sibanda S; Mabhena E; Pasipamire M; Kabore SM; Rusch B; Jamet C; Ciglenecki I; Teck R
BMC Public Health; 2018 Mar; 18(1):374. PubMed ID: 29558896
[TBL] [Abstract][Full Text] [Related]
38. Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.
Atanga PN; Ndetan HT; Achidi EA; Meriki HD; Hoelscher M; Kroidl A
Trop Med Int Health; 2017 Feb; 22(2):161-170. PubMed ID: 27865052
[TBL] [Abstract][Full Text] [Related]
39. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
[TBL] [Abstract][Full Text] [Related]
40. Prevention of Mother-to-Child Transmission of HIV in Option B+ Era: Uptake and Adherence During Pregnancy in Western Uganda.
Schnack A; Rempis E; Decker S; Braun V; Rubaihayo J; Busingye P; Tumwesigye NM; Harms G; Theuring S
AIDS Patient Care STDS; 2016 Mar; 30(3):110-8. PubMed ID: 27308804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
